Article and Video CATEGORIES
Kurt Davies, PhD, Instructor with the University of Colorado Health Sciences Center – Department of Pharmacology, and Nirali Patel MD, Assistant Professor, Department of Pathology and Laboratory Medicine, UNC School of Medicine join GRACE to discuss Molecular Diagnostic Testing and Next Generation Sequencing. This extremely informative (audio only) webinar series discusses cancer cell biology, targeted therapies, genetic testing, the importance of retesting in cases of resistance, and next generation sequencing.
Cancer Cell Biology 101, Presented by Kurtis Davies, PhD, University of Colorado Anschutz Medical Campus
How Targeted Therapies Treat Cancer, Presented by Kurtis Davies, PhD, University of Colorado Anschutz Medical Campus
How it Works: Genetic Testing in Lung Cancer, Presented by Kurtis Davies, PhD, University of Colorado Anschutz Medical Campus
Resistance to Targeted Therapies, and the Importance of Retesting, Presented by Kurtis Davies, PhD, University of Colorado Anschutz Medical Campus
What is Next Generation Sequencing (NGS)? Presented by Nirali Patel MD, Assistant Professor, Department of Pathology and Laboratory Medicine, UNC School of Medicine
GRACE would like to thank the following sponsors for their support of this program
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Forum Discussions
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Recent Comments
That's…